FDA & Regulatory
Orphan Drug Designation
Orphan Drug Designation (ODD) applies to therapies for rare diseases affecting fewer than 200,000 people in the U.S. It confers incentives including tax credits, fee waivers, and seven years of market exclusivity on approval.
- Category
- FDA & Regulatory
- Abbreviation
- ODD
Prepared research question
How does Orphan Drug Designation affect the view of a biotech company in practice?
Traceable citations · Unknowns marked
Orphan Drug Designation (ODD) applies to therapies for rare diseases affecting fewer than 200,000 people in the U.S. It confers incentives including tax credits, fee waivers, and seven years of market exclusivity on approval.
Related terms
Learn more
From term to thesis rule
Investigate how Orphan Drug Designation changes a biotech thesis
Define when Orphan Drug Designation should count, block, or trigger a deeper check; BioSniper will compile that logic against available evidence.